Table 2.
Patient characteristics between pCR and npCR groups.
| Characteristic | pCR | nPCR | P value | Univariate | |
|---|---|---|---|---|---|
| (n = 32) | (n = 42) | Odds ratio (95% CI) | P value | ||
| Age | 0.489 | ||||
| ≤70 | 28 | 33 | Reference | ||
| >70 | 4 | 9 | 0.52 (0.146-1.886) | 0.322 | |
| Gender | 1.000 | ||||
| Male | 26 | 34 | Reference | ||
| Female | 6 | 7 | 1.15 (0.347-3.841) | 0.816 | |
| T stage | 0.424 | ||||
| T1-2 | 3 | 1 | Reference | ||
| T3-4 | 29 | 40 | 0.24 (0.024-2.442) | 0.229 | |
| N stage | 0.809 | ||||
| N0 | 2 | 1 | Reference | ||
| N1-2 | 30 | 40 | 0.38 (0.032-4.331) | 0.432 | |
| Location | 0.182 | ||||
| Upper | 4 | 5 | Reference | ||
| Middle | 8 | 19 | 0.53 (0.111-2.487) | 0.418 | |
| Lower | 20 | 18 | 1.39 (0.322-5.986) | 0.659 | |
| Length of the lesion | 1.000 | ||||
| ≤6.75 cm | 25 | 33 | Reference | ||
| >6.75 cm | 7 | 9 | 1.03 (0.336-3.134) | 0.963 | |
| Chemotherapy | 0.332 | ||||
| Triweekly | 31 | 2 | Reference | ||
| Weekly | 41 | 8 | 1.000 | 0.180 | |
| Tegafur | 2 | 0 | 1.000 | 0.993 | |